Eurobio Scientific Finalizes Acquisition of CareDx Lab Product Division
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
Read MorePosted by CLP Edit Staff | Jul 2, 2026 | Company News, Diagnostic Technologies, Molecular Diagnostics |
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
Read MorePosted by CLP Edit Staff | Jun 22, 2026 | Infectious Diseases, Molecular Diagnostic Analyzers |
The point-of-care assay provides results in 15 minutes and received a waiver for use in decentralized settings.
Read MorePosted by CLP Edit Staff | Jun 16, 2026 | Flu & Respiratory Infections, Molecular Diagnostics |
The system simultaneously detects RSV, influenza A and B, and SARS-CoV-2 from a nasal swab in under 10 minutes.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
Emerging Andes virus cases—capable of person-to-person transmission—are prompting US clinical labs to reassess hantavirus protocols and consider travel and epidemiologic exposures beyond rodent contact.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Company News, Infectious Diseases, Molecular Diagnostics |
Co-Diagnostics has completed its assay development strategy for Bundibugyo virus, following the WHO’s emergency declaration and CDC’s updated traveler screening measures amid ongoing Ebola outbreaks in the DRC and Uganda.
Read More